Back to Trades
Breen Michael Martin
CEO and DirectorDirectorCIK 0001863633
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025
Breen Michael Martin, CEO and Director, Director, accounts for 1 disclosed filing worth $399.0K, all concentrated in GT Biopharma, Inc. (GTBP), active 2025. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Sep 8 | GTBP GT Biopharma, Inc. | Breen Michael Martin | CEO and Director, Director | Award | $399.0K |
1 filing